Previous close | 80.30 |
Open | 80.30 |
Bid | 93.40 |
Ask | 96.40 |
Strike | 220.00 |
Expiry date | 2024-04-19 |
Day's range | 80.05 - 80.30 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock rises 13%.
Carnival (NYSE: CCL) (NYSE: CUK) shares have climbed 95% this year, but they're still trading way below their pre-pandemic levels. Things weren't easy for Carnival at the start of the health crisis since it was forced to halt sailings -- and debt ballooned so the company could stay afloat. Carnival's latest earnings reports offer us reason to be optimistic.
Market performance hangs on U.S. vaccination rates for these three companies.